Posted By Scott Deeter on 11/20/18 8:31 AM
Posted By Randy Alfano Ph.D. on 9/10/18 9:48 AM
We are pleased to announce that on Tuesday, September 18th InVitria will be hosting a webinar in partnership with Genetic Engineering & Biotechnology News!
Here is the webinar abstract:
The advent of recombinant antibody production in mammalian cell lines has revolutionized modern medicine. Clinical success of these agents has challenged the underlying biological manufacturing systems to produce quantities sufficient to supply the ever-expanding commercial markets.
Posted By Scott Deeter on 8/3/18 8:34 AM
To enable further growth and expansion of our team and operations, InVitria is moving our Colorado location to Anschutz Medical Campus. The larger facility will help the InVitria team as we continue to expand our product line of blood-free supplements, components and media to facilitate the approval of life changing medicines.
Last week InVitria attended and celebrated the 25th anniversary of the Biotechnology Industry Organization (BIO) at their annual conference. More than 18,000 delegates over 7,000 companies flew in from around the world and joined InVitria at this event in Boston. A few highlights that emerged from the BIO 2018 conference include:
Posted By Randy Alfano Ph.D. on 5/18/18 9:59 AM
This year at the American Association of Immunologists 2018 Conference in Austin, Texas, I had the pleasure of meeting some of the field’s brightest scientists deep in my home town. While enjoying only a small sample of blues, rock, country music and some Texas-authentic Tex-Mex that the live music capital of the world has to offer, I was able to catch up on some of the latest developments in the field, network with colleagues, and speak with scientists presenting their latest research.